23andMe Holding Co. (NASDAQ:ME) Short Interest Update

23andMe Holding Co. (NASDAQ:ME - Get Free Report) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 28,090,000 shares, a decline of 23.4% from the May 31st total of 36,690,000 shares. Approximately 9.9% of the company's shares are short sold. Based on an average daily volume of 5,250,000 shares, the short-interest ratio is currently 5.4 days.

Analysts Set New Price Targets

Separately, Citigroup cut their price target on 23andMe from $0.85 to $0.47 and set a "neutral" rating on the stock in a research note on Tuesday, April 16th.

23andMe Price Performance

Shares of NASDAQ ME traded down $0.03 during mid-day trading on Friday, hitting $0.39. The company's stock had a trading volume of 38,544,121 shares, compared to its average volume of 4,697,669. The stock has a market cap of $191.79 million, a price-to-earnings ratio of -0.28 and a beta of 1.27. The company's fifty day simple moving average is $0.48 and its 200-day simple moving average is $0.59. 23andMe has a one year low of $0.35 and a one year high of $2.03.

23andMe (NASDAQ:ME - Get Free Report) last announced its quarterly earnings data on Thursday, May 23rd. The company reported ($0.12) earnings per share (EPS) for the quarter. The business had revenue of $64.03 million during the quarter, compared to the consensus estimate of $61.90 million. 23andMe had a negative net margin of 303.55% and a negative return on equity of 66.15%.

Institutional Investors Weigh In On 23andMe

A number of institutional investors have recently made changes to their positions in the stock. Wittenberg Investment Management Inc. grew its holdings in shares of 23andMe by 63.9% in the 1st quarter. Wittenberg Investment Management Inc. now owns 2,290,945 shares of the company's stock valued at $1,219,000 after buying an additional 893,552 shares during the period. Vanguard Group Inc. increased its holdings in shares of 23andMe by 3.1% in the third quarter. Vanguard Group Inc. now owns 28,145,216 shares of the company's stock worth $27,518,000 after acquiring an additional 834,504 shares in the last quarter. Mirador Capital Partners LP acquired a new stake in shares of 23andMe during the fourth quarter worth about $280,000. BKA Wealth Consulting Inc. bought a new position in shares of 23andMe during the 4th quarter valued at about $126,000. Finally, SG Americas Securities LLC grew its position in shares of 23andMe by 61.4% in the 4th quarter. SG Americas Securities LLC now owns 214,004 shares of the company's stock valued at $195,000 after purchasing an additional 81,442 shares during the period. 36.10% of the stock is owned by institutional investors and hedge funds.

About 23andMe

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.